Skip to main content
. 2021 Jul 27;15:11782234211034937. doi: 10.1177/11782234211034937

Figure 3.

Figure 3.

Human (BT-549-GFP; MDA-MB-231) or murine (66.1; 410.4) cells placed in upper wells of migration chamber and allowed to migrate in response to 2% FBS in the absence or presence of TE in the upper and lower chamber, at the indicated concentrations or vehicle control for 18 to 20 hours. Cells in lower chamber stained with calcein AM, dislodged with colorless trypsin, and cell number estimated. Ex-485; Emi-520. Mean migration ± SE of triplicate determinations expressed as % inhibition versus PBS-treated cells. For BT549-GFP, 66.1, and 4104 cells, P values are *P < .04; **P < .003; ***P < .0006. For MDA-MB-231 cells, P values are *P < .04; **P < .02. FBS indicates fetal bovine serum; PBS, phosphate-buffered saline; TE, taro extract.